
CKPT
Healthcare · Biotechnology · $370.7M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2025
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 8, 2025 | Before the open | -0.10 | -0.19 | -90.0% |
| Mar 20, 2025 | Before the open | -0.19 | -0.69 | -263.2% |
| Nov 11, 2024 | After the close | -0.15 | -0.23 | -53.3% |
| Aug 12, 2024 | Before the open | -0.30 | -0.18 | +40.0% |
| May 10, 2024 | Before the open | -0.27 | -0.33 | -22.2% |
| Mar 22, 2024 | Before the open | -0.54 | -1.10 | -103.7% |
| Nov 13, 2023 | After the close | -0.76 | -0.29 | +61.8% |
| Aug 14, 2023 | After the close | -0.78 | -1.05 | -34.6% |
| May 15, 2023 | After the close | -1.07 | -0.89 | +16.8% |
| Mar 31, 2023 | After the close | -1.31 | -2.29 | -74.8% |
| Nov 8, 2022 | After the close | -1.47 | -1.20 | +18.4% |
| Aug 12, 2022 | Before the open | -1.72 | -1.60 | +7.0% |
| May 12, 2022 | After the close | -1.42 |
Checkpoint Therapeutics, Inc., a commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is UNLOXCYT, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers;…
| -2.00 |
| -40.8% |
| Mar 28, 2022 | Before the open | -1.54 | -3.90 | -153.2% |
| Nov 4, 2021 | After the close | -1.36 | -1.40 | -2.9% |
| Aug 5, 2021 | After the close | -1.04 | -1.20 | -15.4% |
| May 6, 2021 | After the close | -1.05 | -0.90 | +14.3% |
| Mar 9, 2021 | After the close | -0.80 | -1.70 | -112.5% |
| Nov 4, 2020 | After the close | -0.80 | -0.90 | -12.5% |
| Aug 5, 2020 | After the close | -0.90 | -0.90 | 0.0% |
| May 6, 2020 | After the close | -1.27 | -0.60 | +52.8% |
| Mar 11, 2020 | After the close | -1.67 | -2.20 | -31.7% |
| Nov 7, 2019 | After the close | -1.67 | -1.50 | +10.2% |
| Aug 8, 2019 | After the close | -1.70 | -1.50 | +11.8% |
| May 9, 2019 | After the close | -2.70 | -1.80 | +33.3% |
| Mar 15, 2019 | Before the open | -2.95 | -3.80 | -28.8% |
| Nov 2, 2018 | Before the open | -2.30 | -3.20 | -39.1% |
| Aug 7, 2018 | After the close | -3.40 | -2.30 | +32.4% |
| May 10, 2018 | After the close | -2.00 | -3.50 | -75.0% |
| Mar 15, 2018 | After the close | -3.05 | -2.60 | +14.8% |